Federal Circuit upholds ruling in Roche TB patent clash
The US Court of Appeals for the Federal Circuit yesterday upheld a district court ruling that invalidated a patent owned by Roche Molecular Systems, a division of Roche that makes equipment and reagents.
Sidley Austin adds partner from King & Spalding
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding.
Duke University and Allergan drop Alcon dispute
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.
Canadian generics group hits out at trade deal
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association.
USITC to probe ResMed following Fisher & Paykel complaint
The US International Trade Commission has voted to begin an investigation into US medical device maker ResMed following a complaint from New Zealand-based rival Fisher & Paykel Healthcare.
O’Melveny hires partner from Paul Hastings
US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York.
PTAB grants IPR win to Celltrion over Biogen
The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion.
Janssen and Arrowhead strike RNAi deal
Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals.
MHRA seeks public views on no-deal Brexit
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario.
Boston Pharma reaches deals with GSK and Novartis
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total.
